Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Perennial Malaria Chemoprevention in the Malaria Vaccine Era [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating perennial malaria chemoprevention in the malaria vaccine era. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Malaria, Falciparum | Phase 4 | Status: NOT_YET_RECRUITING